Outcomes with De Novo Sirolimus/Mycophenolate Mofetil (MMF) Versus Tacrolimus/MMF in High-Risk Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction

被引:0
|
作者
Centeno, A. [1 ]
Duhart, B., Jr. [1 ]
Krauss, A. [1 ]
Patel, S. [2 ]
Rao, V. [1 ]
Eason, J. [1 ]
机构
[1] Methodist Univ Hosp UTHSC, Memphis, TN USA
[2] Methodist Hosp, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
1312
引用
收藏
页码:412 / 412
页数:1
相关论文
共 50 条
  • [41] Evaluation of Graft Outcomes between Tacrolimus and Sirolimus-Based Regimens in Hepatitis C Liver Transplant Recipients Receiving Rabbit Antithymocyte Globulin Induction.
    Wilson, Nikita
    Duhart, Benjamin, Jr.
    Krauss, Amy
    Dryn, Oleksandra
    Bogard, Donna
    Eason, James
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 530 - 530
  • [42] SAFETY AND EFFICACY OF LOW DOSE AND VERY LOW DOSE EXTENDED-RELEASE TACROLIMUS/MMF IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Narumi, Shunji
    Watarai, Yoshihiko
    Goto, Norihiko
    Hiramitsu, Takahisa
    Tsujita, Makoto
    Yamamoto, Takayuki
    Okada, Manabu
    Itoh, Kenta
    Kobayashi, Takaaki
    TRANSPLANT INTERNATIONAL, 2015, 28 : 269 - 269
  • [43] Comparison of Low Dose and Very Low Dose Extended-Release Tacrolimus / MMF in De Novo Kidney Transplant Recipients.
    Watarai, Y.
    Okada, M.
    Futamura, K.
    Nagai, T.
    Yamamoto, T.
    Tsujita, M.
    Hiramitsu, T.
    Goto, N.
    Narumi, S.
    Kobayashi, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 535 - 535
  • [44] 12 month report of a 3 arm multicenter comparison of tacrolimus (TAC), MMF or TAC/sirolimus(SRL) and steroids vs cyclosporine microemulsion(CYA), MMF and steroids in de novo cardiac transplant recipients
    Kobashigawa, J. W.
    Miller, L. W.
    Felker, G. M.
    Russel, S. D.
    Ewald, G. A.
    Zucker, M.
    Goldberg, L.
    Eisen, H. J.
    Rayburn, B. K.
    Wagoner, L. E.
    Philbin, E.
    Pereira, N.
    Czerska, B.
    Kormos, R. L.
    Weston, M.
    Conte, J.
    Hosenpud, J.
    Aaronson, K.
    Hill, J.
    Copeland, J. G.
    Czer, L.
    Anderson, A.
    Dec, G. W.
    Torre-Amione, G.
    Yancy, C. W.
    Vega, J. D.
    Jarcho, J. A.
    Mancini, D.
    Bhat, G.
    First, R.
    Fitzsimmons, W.
    Tolzman, D.
    Salm, K.
    Gao, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S61 - S62
  • [45] Prospective Randomized Trial of Sirolimus (SRL) and Mycophenolate Mofetil (MMF) vs. Tacrolimus (TAC) plus MMF Therapy Following Thymoglobulin (THY) Induction with Rapid Steroid Taper (RST) in Primary Kidney Transplantation (KTX).
    Gonwa, Thomas A.
    Heilman, Raymond L.
    Wadei, Hani M.
    Reddy, Kunam S.
    Mai, Martin L.
    Mazur, Marek
    Ahsan, Nasimul
    Younan, Kerri
    Mulligan, David C.
    Grewal, Hani
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 341 - 341
  • [46] A Comparison of Alemtuzumab versus Antithymocyte Globulin Induction in High-Risk, Non-Sensitized Renal Transplant Recipients.
    Patel, S.
    Lichvar, A.
    Benedetti, E.
    West-Thielke, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 676 - 677
  • [47] PREVALENCE OF SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) IN THE GENES CODING FOR TACROLIMUS (TAC) AND MYCOPHENOLATE MOFETIL (MMF) METABOLIC ENZYMES AND TRANSPORTING PROTEINS IN SPANISH KIDNEY TRANSPLANT RECIPIENTS
    Morales, Jose M.
    Brunet, Merce
    Guirado, Luis
    Marcen, Roberto
    Gentil, Miguel A.
    Gilvernet, Salvador
    Cantarell, Carmen
    Jimeno, Luisa
    TRANSPLANT INTERNATIONAL, 2013, 26 : 84 - 84
  • [48] INCIDENCE OF DELAYED GRAFT FUNCTION (DGF) IN SIROLIMUS (SRL)-BASED REGIMENS COMPARED WITH CALCINEURIN INHIBITORS (CNIs) AND MYCOPHENOLATE MOFETIL (MMF) IN DE NOVO RENAL ALLOGRAFT RECIPIENTS
    Campistol, Josep M.
    Glyda, Maciej
    Gurkan, Alihan
    Flechner, Stuart M.
    Schulman, Seth
    Tai, Sandi See
    TRANSPLANT INTERNATIONAL, 2009, 22 : 121 - 121
  • [49] Preemptive Therapy Versus Valgancyclovir Prophylaxis in Cytomegalovirus-positive Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction
    Couzi, L.
    Helou, S.
    Bachelet, T.
    Martin, S.
    Moreau, K.
    Morel, D.
    Lafon, M. E.
    Garrigue, I.
    Merville, P.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2809 - 2813
  • [50] Preemptive Therapy Versus Valganciclovir Prophylaxis in CMV R plus Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction
    Couzi, L.
    Helou, S.
    Bachelet, T.
    Martin, S.
    Moreau, K.
    Morel, D.
    Lafon, M. -E.
    Garrigue, I.
    Merville, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 469 - 469